about
From UBE3A to Angelman syndrome: a substrate perspectiveAngelman syndrome: A review highlighting musculoskeletal and anatomical aberrations.Delta rhythmicity is a reliable EEG biomarker in Angelman syndrome: a parallel mouse and human analysis.Clinical Application of an Innovative Multiplex-Fluorescent-Labeled STRs Assay for Prader-Willi Syndrome and Angelman Syndrome.Long contiguous stretches of homozygosity spanning shortly the imprinted loci are associated with intellectual disability, autism and/or epilepsy.Spatiotemporal progression of ubiquitin-proteasome system inhibition after status epilepticus suggests protective adaptation against hippocampal injury.Oxytocin and Animal Models for Autism Spectrum Disorder.RETRACTED: A Report on the Internal Retreat Meeting of the Stem Cell Network North Rhine Westphalia.Angelman syndrome: Current and emerging therapies in 2016.Role of DNA methylation in imprinting disorders: an updated review.The Networks of Genes Encoding Palmitoylated Proteins in Axonal and Synaptic Compartments Are Affected in PPT1 Overexpressing Neuronal-Like Cells.Decreased Axon Caliber Underlies Loss of Fiber Tract Integrity, Disproportional Reductions in White Matter Volume, and Microcephaly in Angelman Syndrome Model Mice.Therapeutic Advances in Autism and Other Neurodevelopmental Disorders.Unmet clinical needs and burden in Angelman syndrome: a review of the literature.Subcellular organization of UBE3A in neurons.How Can a Ketogenic Diet Improve Motor Function?Neuronal Proteomic Analysis of the Ubiquitinated Substrates of the Disease-Linked E3 Ligases Parkin and Ube3a.Taurine Administration Recovers Motor and Learning Deficits in an Angelman Syndrome Mouse Model.
P2860
Q26781685-15F401A7-D6BE-4E23-8081-F8757EC16216Q30252074-DA919CA8-3D53-4227-8645-C324914EEA58Q33651529-F57BF92B-3A37-4CEB-AD48-A480DDBB078EQ35913564-BD50B684-AF6A-4512-8D50-9905E4A6166EQ36169475-252E198D-D429-4C3B-B83D-415B5D5E17A6Q37663375-D04744EC-64B6-4578-A3EB-C0D270D48F89Q38634066-90559FC9-386C-4A9A-AF21-D2946990F65AQ38995362-EC006BEA-7902-42B5-A343-814EC8B504E9Q39012491-4E40B015-13BF-41F2-A548-E3BA8877B3D4Q39172425-DBA3A5D9-0881-4581-BD97-8B23FA3FD00EQ41525295-A9D55836-1310-4B5A-B4F2-61D506C0C98BQ41919268-59668378-CDB6-4E6A-A5EA-1E7F11556754Q42368784-938067FF-5075-4369-965E-AFDFC90AAB1DQ42689806-515D3D23-09E5-4671-832E-B9B480A932EBQ48658877-EC364DA6-06F5-449F-9CCF-5168F31A324EQ49620553-D42F4AED-241A-4378-A7B8-1F70E9309DE9Q52564493-6476ADF0-A97A-4A78-B1DD-9482D2133A8DQ52604692-4862EFD0-9B11-4491-8136-F150E1CF89C3
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Angelman Syndrome.
@ast
Angelman Syndrome.
@en
type
label
Angelman Syndrome.
@ast
Angelman Syndrome.
@en
prefLabel
Angelman Syndrome.
@ast
Angelman Syndrome.
@en
P2093
P2860
P1433
P1476
Angelman Syndrome
@en
P2093
Gabrielle L Sell
Mark A Zbinden
Seth S Margolis
P2860
P2888
P304
P356
10.1007/S13311-015-0361-Y
P50
P577
2015-07-01T00:00:00Z